Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 408,277
  • Shares Outstanding, K 93,214
  • Annual Sales, $ 837,600 K
  • Annual Income, $ -127,300 K
  • EBIT $ -82 M
  • EBITDA $ 36 M
  • 60-Month Beta 1.90
  • Price/Sales 0.49
  • Price/Cash Flow 4.29
  • Price/Book 1.07

Options Overview Details

View History
  • Implied Volatility 208.45% (-87.48%)
  • Historical Volatility 38.85%
  • IV Percentile 71%
  • IV Rank 29.13%
  • IV High 586.89% on 02/19/26
  • IV Low 52.89% on 08/12/25
  • Expected Move (DTE 24) 0.65 (14.77%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 354
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 1,156
  • Open Int (30-Day) 1,909
  • Expected Range 3.78 to 5.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.11
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.10 +8.05%
on 02/23/26
5.97 -25.80%
on 01/26/26
-1.44 (-24.53%)
since 01/23/26
3-Month
4.10 +8.05%
on 02/23/26
8.09 -45.21%
on 11/25/25
-3.30 (-42.69%)
since 11/24/25
52-Week
3.76 +17.82%
on 08/01/25
12.28 -63.93%
on 02/25/25
-9.35 (-67.85%)
since 02/24/25

Most Recent Stories

More News
Why Myriad Genetics (MYGN) Stock Is Trading Up Today

Why Myriad Genetics (MYGN) Stock Is Trading Up Today

MYGN : 4.43 (+1.14%)
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests

SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will present new data at the 2026 ASCO-GU conference...

MYGN : 4.43 (+1.14%)
Myriad: Q4 Earnings Snapshot

Myriad: Q4 Earnings Snapshot

MYGN : 4.43 (+1.14%)
Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%

Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%

MYGN : 4.43 (+1.14%)
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Highl ights Fourth quarter 2025 revenue of $209.8 million was consistent with fourth quarter 2024 revenue, but grew 4% year-over-year when excluding the previously discussed headwind 1...

MYGN : 4.43 (+1.14%)
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

FTRE : 10.32 (-4.80%)
GDRX : 2.37 (+4.41%)
AGL : 0.3940 (-9.15%)
MYGN : 4.43 (+1.14%)
IRTC : 137.10 (-2.92%)
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test

SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced the publication of the analytical...

MYGN : 4.43 (+1.14%)
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

SALT LAKE CITY, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular testing and precision medicine, will hold its fourth quarter and full year 2025 earnings...

MYGN : 4.43 (+1.14%)
3 Cash-Burning Stocks We Keep Off Our Radar

3 Cash-Burning Stocks We Keep Off Our Radar

FLWS : 3.31 (+2.48%)
TLYS : 1.3800 (-1.43%)
MYGN : 4.43 (+1.14%)
1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm

1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm

MYGN : 4.43 (+1.14%)
DBI : 7.38 (-1.07%)
BGC : 9.28 (-1.17%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 6.63
2nd Resistance Point 6.17
1st Resistance Point 5.30
Last Price 4.43
1st Support Level 3.97
2nd Support Level 3.51
3rd Support Level 2.64

See More

52-Week High 12.28
Fibonacci 61.8% 9.03
Fibonacci 50% 8.02
Fibonacci 38.2% 7.01
Last Price 4.43
52-Week Low 3.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar